Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China
· Delayed Price · Currency is CNY 281.00
+25.94 (10.17%)
At close: Mar 10, 2026
SHA:688506 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 105,308 | 133,400 | 76,884 | 56,100 | - | - | Upgrade
|
| Market Cap Growth | 47.15% | 73.51% | 37.05% | - | - | - | Upgrade
|
| Enterprise Value | 102,921 | 131,013 | 73,458 | 56,019 | - | - | Upgrade
|
| Last Close Price | 255.06 | 323.10 | 191.73 | 139.90 | - | - | Upgrade
|
| PE Ratio | - | - | 20.74 | - | - | - | Upgrade
|
| Forward PE | - | - | 71.91 | - | - | - | Upgrade
|
| PS Ratio | 41.79 | 52.93 | 13.20 | 99.85 | - | - | Upgrade
|
| PB Ratio | 14.69 | 18.60 | 19.79 | 369.39 | - | - | Upgrade
|
| P/TBV Ratio | 14.75 | 18.68 | 19.92 | 452.87 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 19.34 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 18.94 | - | - | - | Upgrade
|
| EV/Sales Ratio | 40.84 | 51.99 | 12.62 | 99.70 | - | - | Upgrade
|
| EV/EBITDA Ratio | - | - | 19.57 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 19.93 | - | - | - | Upgrade
|
| EV/FCF Ratio | - | - | 18.48 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.53 | 0.53 | 0.53 | 4.53 | 0.59 | 0.87 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.55 | - | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.52 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.33 | -0.95 | 1.87 | -0.49 | 0.40 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.67 | 3.67 | -0.98 | -0.39 | 1.68 | -1.21 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -0.93 | -0.41 | 1.56 | -0.74 | Upgrade
|
| Asset Turnover | - | - | 1.36 | 0.33 | 0.48 | 0.80 | Upgrade
|
| Inventory Turnover | - | - | 1.87 | 2.00 | 2.59 | 2.75 | Upgrade
|
| Quick Ratio | - | - | 2.99 | 0.52 | 1.73 | 0.62 | Upgrade
|
| Current Ratio | - | - | 3.19 | 0.74 | 1.94 | 0.90 | Upgrade
|
| Return on Equity (ROE) | -19.00% | -19.00% | 183.64% | -143.77% | -44.62% | -25.51% | Upgrade
|
| Return on Assets (ROA) | - | - | 53.82% | -28.74% | -14.01% | -10.00% | Upgrade
|
| Return on Invested Capital (ROIC) | -15.01% | -28.80% | 1077.87% | -172.17% | -70.10% | -38.81% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 71.50% | -211.60% | -26.30% | -33.20% | Upgrade
|
| Earnings Yield | -1.00% | -0.79% | 4.82% | -1.39% | - | - | Upgrade
|
| FCF Yield | - | - | 5.17% | -1.24% | - | - | Upgrade
|
| Payout Ratio | - | - | 1.03% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -3.20% | -3.20% | -0.14% | -10.56% | -1.38% | -3.64% | Upgrade
|
| Total Shareholder Return | -3.20% | -3.20% | -0.14% | -10.56% | -1.38% | -3.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.